HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory reform bill clears Senate Judiciary Committee on April 27.

This article was originally published in The Rose Sheet

Executive Summary

SENATE JUDICIARY COMMITTEE REPORTS OUT REGULATORY REFORM BILL S 343 on April 27 under a unanimous consent agreement. An April 26 mark-up was postponed by a day because of the funeral of former Mississippi Sen. John Stennis. Chairman Orrin Hatch (R-UT) declared the bill reported out favorably as of 6 p.m. April 26 after a contentious half-hour session during which Sens. Edward Kennedy (D-MA) and Joseph Biden (D-DE) maintained that the bill should not be reported out of committee until all amendments had been discussed.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001587

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel